Journal of Breast Disease

Korean Breast Cancer Society (한국유방암학회)
권호 표지
DOI QR코드

DOI QR Code

Apoptosis and Cell Cycle Arrest in Two Human Breast Cancer Cell Lines by Dieckol Isolated from Ecklonia cava

  • You, Sun Hyong (Department of Surgery, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jeong-Soo (Department of Surgery, College of Medicine, The Catholic University of Korea) ;
  • Kim, Yong-Seok (Department of Surgery, College of Medicine, The Catholic University of Korea)
  • Received : 2018.05.16
  • Accepted : 2018.08.28
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Purpose: Dieckol, a phlorotannin compound isolated from Ecklonia cava, has been reported to have antioxidant, antiviral, anti-inflammatory, and anticancer properties. The purpose of this study was to investigate its anticancer effects on human breast cancer cell lines. Methods: In this study, the viability of two human breast cancer cell lines SK-BR-3 and MCF-7 was investigated after dieckol treatment using a WST-1 assay. Apoptosis and cell cycle distribution were assayed via Annexin V-fluorescein isothiocyanate and propidium iodide staining followed by flow cytometric analysis. Immunoblotting analysis was also performed using Bax/Bcl-2 to determine whether the dieckol-induced apoptosis was mediated by the intrinsic apoptotic pathway. Results: In a dose dependent manner, dieckol reduced the number of viable cells and increased the number of apoptotic cells. The effect of dieckol on the cell cycle distribution was analyzed using flow cytometry. Dieckol treatment significantly increased the percentage of MCF-7 and SK-BR-3 in the G2/M phase. Immunoblot analysis revealed that 24 hours of dieckol exposure increased the Bax/Bcl-2 ratio. Conclusion: Dieckol induced cytotoxicity in MCF-7 and SK-BR-3 human breast cancer cells inducing apoptosis and cell cycle arrest. Therefore, it is suggested that dieckol may be a potential therapeutic agent for breast cancer.

Keywords

References

  1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:52-62. https://doi.org/10.3322/caac.21203
  2. Lee JH, Shim JW, Choi YJ, Heo K, Yang K. The combination of sorafenib and radiation preferentially inhibits breast cancer stem cells by suppressing HIF-$1{\alpha}$ expression. Oncol Rep 2013;29:917-24. https://doi.org/10.3892/or.2013.2228
  3. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406:747-52. https://doi.org/10.1038/35021093
  4. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74. https://doi.org/10.1073/pnas.191367098
  5. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393-8. https://doi.org/10.1073/pnas.1732912100
  6. Omidvari S, Hamedi SH, Mohammadianpanah M, Nasrolahi H, Mosalaei A, Talei A, et al. Very late relapse in breast cancer survivors: a report of 6 cases. Iran J Cancer Prev 2013;6:113-7.
  7. Tew WP, Muss HB, Kimmick GG, Von Gruenigen VE, Lichtman SM. Breast and ovarian cancer in the older woman. J Clin Oncol 2014;32:2553-61. https://doi.org/10.1200/JCO.2014.55.3073
  8. Lemieux J, Provencher L, Laflamme C. Survey about the use of scalp cooling to prevent alopecia during breast cancer chemotherapy treatment in Canada. Can Oncol Nurs J 2014;24:102-8.
  9. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2010;2:2490-518. https://doi.org/10.3390/toxins2112490
  10. Bonofiglio D, Giordano C, De Amicis F, Lanzino M, Ando S. Natural products as promising antitumoral agents in breast cancer: mechanisms of action and molecular targets. Mini Rev Med Chem 2016;16:596-604. https://doi.org/10.2174/1389557515666150709110959
  11. Vadodkar AS, Suman S, Lakshmanaswamy R, Damodaran C. Chemoprevention of breast cancer by dietary compounds. Anticancer Agents Med Chem 2012;12:1185-202. https://doi.org/10.2174/187152012803833008
  12. Wijesinghe WA, Jeon YJ. Exploiting biological activities of brown seaweed Ecklonia cava for potential industrial applications: a review. Int J Food Sci Nutr 2012;63:225-35. https://doi.org/10.3109/09637486.2011.619965
  13. Kim SK, Lee DY, Jung WK, Kim JH, Choi I, Park SG, et al. Effects of Ecklonia cava ethanolic extracts on airway hyperresponsiveness and inflammation in a murine asthma model: role of suppressor of cytokine signaling. Biomed Pharmacother 2008;62:289-96. https://doi.org/10.1016/j.biopha.2007.07.009
  14. Kang HS, Chung HY, Kim JY, Son BW, Jung HA, Choi JS. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch Pharm Res 2004;27:194-8. https://doi.org/10.1007/BF02980106
  15. Kim TH, Ku SK, Bae JS. Antithrombotic and profibrinolytic activities of eckol and dieckol. J Cell Biochem 2012;113:2877-83. https://doi.org/10.1002/jcb.24163
  16. Ahn JH, Yang YI, Lee KT, Choi JH. Dieckol, isolated from the edible brown algae Ecklonia cava, induces apoptosis of ovarian cancer cells and inhibits tumor xenograft growth. J Cancer Res Clin Oncol 2015;141:255-68. https://doi.org/10.1007/s00432-014-1819-8
  17. Kim EK, Tang Y, Kim YS, Hwang JW, Choi EJ, Lee JH, et al. First evidence that Ecklonia cava-derived dieckol attenuates MCF-7 human breast carcinoma cell migration. Mar Drugs 2015;13:1785-97. https://doi.org/10.3390/md13041785
  18. Lee SM, Bae SK, Kim TH, Yoon HK, Jung SJ, Park JS, et al. Value of 18F-FDG PET/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy. Clin Nucl Med 2014;39:882-6. https://doi.org/10.1097/RLU.0000000000000531
  19. Li Y, Qian ZJ, Ryu B, Lee SH, Kim MM, Kim SK. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg Med Chem 2009;17:1963-73. https://doi.org/10.1016/j.bmc.2009.01.031
  20. Heo SJ, Ko SC, Cha SH, Kang DH, Park HS, Choi YU, et al. Effect of phlorotannins isolated from Ecklonia cava on melanogenesis and their protective effect against photo-oxidative stress induced by UV-B radiation. Toxicol In Vitro 2009;23:1123-30. https://doi.org/10.1016/j.tiv.2009.05.013
  21. Nagayama K, Iwamura Y, Shibata T, Hirayama I, Nakamura T. Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome. J Antimicrob Chemother 2002;50:889-93. https://doi.org/10.1093/jac/dkf222
  22. Shin HC, Hwang HJ, Kang KJ, Lee BH. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res 2006;29:165-71. https://doi.org/10.1007/BF02974279
  23. Joe MJ, Kim SN, Choi HY, Shin WS, Park GM, Kang DW, et al. The inhibitory effects of eckol and dieckol from Ecklonia stolonifera on the expression of matrix metalloproteinase-1 in human dermal fibroblasts. Biol Pharm Bull 2006;29:1735-9. https://doi.org/10.1248/bpb.29.1735
  24. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007;35:495-516. https://doi.org/10.1080/01926230701320337
  25. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407: 770-6. https://doi.org/10.1038/35037710
  26. MacLachlan TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 1995;5:127-56. https://doi.org/10.1615/CritRevEukarGeneExpr.v5.i2.20
  27. Hartwell LH, Weinert TA. Checkpoints: controls that ensure the order of cell cycle events. Science 1989;246:629-34. https://doi.org/10.1126/science.2683079
  28. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63. https://doi.org/10.1101/gad.9.10.1149
  29. Luk SC, Siu SW, Lai CK, Wu YJ, Pang SF. Cell cycle arrest by a natural product via G2/M checkpoint. Int J Med Sci 2005;2:64-9.
  30. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8. https://doi.org/10.1126/science.7997877

Cited by

  1. Physicochemical characteristics of the active fractions of polyphenols from Arctic macrophytes vol.32, pp.6, 2018, https://doi.org/10.1007/s10811-020-02226-w
  2. Antitumor Activity of Fucus vesiculosus-Derived Phlorotannins through Activation of Apoptotic Signals in Gastric and Colorectal Tumor Cell Lines vol.22, pp.14, 2018, https://doi.org/10.3390/ijms22147604
  3. Dieckol: a brown algal phlorotannin with biological potential vol.142, pp.None, 2018, https://doi.org/10.1016/j.biopha.2021.111988